Literature DB >> 6345501

Brief report: effects of propranolol in Tourette syndrome.

J Sverd, S Cohen, J A Camp.   

Abstract

Alternate medications for the treatment of Tourette syndrome are required because haloperidol in some patients either may be ineffective or may cause disturbing side effects. Propranolol, a beta-adrenergic blocking agent, has been reported as effective, in uncontrolled trials, in ameliorating symptoms of tic disorder, tardive dyskinesia, and drug-induced extrapyramidal syndrome. Propranolol, in doses up to 120 mg per day, was administered to five patients with Tourette syndrome in a placebo-controlled study and was found ineffective in ameliorating symptoms of Tourette syndrome. Results underscored the importance of placebo-controlled investigation when evaluating the effects of drugs in Tourette syndrome.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345501     DOI: 10.1007/bf01531821

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  13 in total

1.  Iatrogenic dyskinesia. A unique reaction to parenteral methylphenidate.

Authors:  D M Palatucci
Journal:  J Nerv Ment Dis       Date:  1974-07       Impact factor: 2.254

2.  Beta-blocking drugs and anxiety.

Authors:  R Noyes
Journal:  Psychosomatics       Date:  1982-02       Impact factor: 2.386

3.  Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.

Authors:  R Chaudhry; D Radonjic; B Waters
Journal:  Am J Psychiatry       Date:  1982-05       Impact factor: 18.112

Review 4.  Is propranolol antischizophrenic?

Authors:  M Peet
Journal:  Neuropharmacology       Date:  1981-12       Impact factor: 5.250

5.  The treatment and etiology of tics and Tourette syndrome.

Authors:  A K Shapiro; E Shapiro
Journal:  Compr Psychiatry       Date:  1981 Mar-Apr       Impact factor: 3.735

6.  Low-dose propranolol in tardive dyskinesia.

Authors:  N M Bacher; H A Lewis
Journal:  Am J Psychiatry       Date:  1980-04       Impact factor: 18.112

7.  The effect of propranolol and its isomers on Purkinje neurones in rat cerebellum.

Authors:  D Yeroukalis; B Alevizos; S Gatzonis; C Stefanis
Journal:  Neuropharmacology       Date:  1981-04       Impact factor: 5.250

8.  Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure.

Authors:  R L Tackett; J G Webb; P J Privitera
Journal:  Science       Date:  1981-08-21       Impact factor: 47.728

9.  The effect of dl-, l- and d-Propranolol on central monoamine neurones I. Studies on dopamine mechanisms.

Authors:  K Fuxe; P Bolme; L Agnati; B J Everitt
Journal:  Neurosci Lett       Date:  1976-09       Impact factor: 3.046

10.  School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder.

Authors:  E J Mikkelsen; J Detlor; D J Cohen
Journal:  Am J Psychiatry       Date:  1981-12       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.